增液承气汤加减联合奥氮平治疗阳明腑实型精神分裂症的效果

R749.3; 背景 阳明腑实型精神分裂症患者症状较重,抗精神病药物的治疗效果有限且副反应较大.目前,缺乏增液承气汤治疗阳明腑实型精神分裂症的临床研究.目的 探讨增液承气汤加减联合奥氮平治疗阳明腑实型精神分裂症的效果,以期为精神分裂症的中西医结合治疗提供参考.方法 选取2022年1月—2023年8月于新乡医学院第二附属医院治疗的、符合《国际疾病分类(第10版)》(ICD-10)精神分裂症诊断标准的阳明腑实型患者60例,采用随机数字表法分为研究组和对照组各30例.两组均接受奥氮平治疗,研究组在此基础上联合增液承气汤加减治疗,两组均治疗4周.在基线期及治疗后,使用阳性和阴性症状量表(PANSS)、...

Full description

Saved in:
Bibliographic Details
Published in四川精神卫生 Vol. 37; no. 5; pp. 403 - 408
Main Authors 王维丽, 邓丽, 王虹郁, 杨世昌, 崔桂梅
Format Journal Article
LanguageChinese
Published 新乡市精神神经疾病中西医诊疗重点实验室,河南 新乡 453002 2024
新乡医学院第二附属医院,河南 新乡 453002%新乡医学院第二附属医院,河南 新乡 453002
Subjects
Online AccessGet full text
ISSN1007-3256
DOI10.11886/scjsws20240220002

Cover

Abstract R749.3; 背景 阳明腑实型精神分裂症患者症状较重,抗精神病药物的治疗效果有限且副反应较大.目前,缺乏增液承气汤治疗阳明腑实型精神分裂症的临床研究.目的 探讨增液承气汤加减联合奥氮平治疗阳明腑实型精神分裂症的效果,以期为精神分裂症的中西医结合治疗提供参考.方法 选取2022年1月—2023年8月于新乡医学院第二附属医院治疗的、符合《国际疾病分类(第10版)》(ICD-10)精神分裂症诊断标准的阳明腑实型患者60例,采用随机数字表法分为研究组和对照组各30例.两组均接受奥氮平治疗,研究组在此基础上联合增液承气汤加减治疗,两组均治疗4周.在基线期及治疗后,使用阳性和阴性症状量表(PANSS)、蒙特利尔认知评估量表(MoCA)及事件相关电位P300评定,并于治疗后记录不良反应发生情况.结果 研究组治疗总有效率高于对照组(χ2=9.320,P=0.002);治疗后,研究组PANSS各分量表评分及总评分均低于对照组,差异均有统计学意义(F=10.287、8.258、8.844、20.079,P均<0.01);研究组MoCA延迟回忆和定向力评分均高于对照组,差异均有统计学意义(F=4.463、22.255,P<0.05或0.01);研究组事件相关电位P300中P3波幅高于对照组,差异有统计学意义(F=4.247,P<0.05);研究组肝功能异常、便秘、体质量指数(BMI)增加的发生率均低于对照组,差异均有统计学意义(χ2=4.320、4.463、7.200,P<0.05或0.01).结论 增液承气汤加减联合奥氮平治疗可能有助于改善阳明腑实型精神分裂症患者的精神病性症状及认知功能,且安全性较好.
AbstractList R749.3; 背景 阳明腑实型精神分裂症患者症状较重,抗精神病药物的治疗效果有限且副反应较大.目前,缺乏增液承气汤治疗阳明腑实型精神分裂症的临床研究.目的 探讨增液承气汤加减联合奥氮平治疗阳明腑实型精神分裂症的效果,以期为精神分裂症的中西医结合治疗提供参考.方法 选取2022年1月—2023年8月于新乡医学院第二附属医院治疗的、符合《国际疾病分类(第10版)》(ICD-10)精神分裂症诊断标准的阳明腑实型患者60例,采用随机数字表法分为研究组和对照组各30例.两组均接受奥氮平治疗,研究组在此基础上联合增液承气汤加减治疗,两组均治疗4周.在基线期及治疗后,使用阳性和阴性症状量表(PANSS)、蒙特利尔认知评估量表(MoCA)及事件相关电位P300评定,并于治疗后记录不良反应发生情况.结果 研究组治疗总有效率高于对照组(χ2=9.320,P=0.002);治疗后,研究组PANSS各分量表评分及总评分均低于对照组,差异均有统计学意义(F=10.287、8.258、8.844、20.079,P均<0.01);研究组MoCA延迟回忆和定向力评分均高于对照组,差异均有统计学意义(F=4.463、22.255,P<0.05或0.01);研究组事件相关电位P300中P3波幅高于对照组,差异有统计学意义(F=4.247,P<0.05);研究组肝功能异常、便秘、体质量指数(BMI)增加的发生率均低于对照组,差异均有统计学意义(χ2=4.320、4.463、7.200,P<0.05或0.01).结论 增液承气汤加减联合奥氮平治疗可能有助于改善阳明腑实型精神分裂症患者的精神病性症状及认知功能,且安全性较好.
Abstract_FL Background Patients with schizophrenia of Yangming Fushi syndrome experience more severe symptoms,and a substantial proportion of patients derive inadequate benefit from antipsychotics and suffer from serious adverse effects,yet few studies have been conducted on the treatment of schizophrenia of Yangming Fushi syndrome with Zengye Chengqi decoction.Objective To explore the efficacy of Zengye Chengqi decoction combined with olanzapine in the treatment of schizophrenia of Yangming Fushi syndrome,in order to provide references for the treatment of schizophrenia with the combination of traditional Chinese and western medicine.Methods A total of 60 patients attending the Second Affiliated Hospital of Xinxiang Medical College from January 2022 to August 2023 and fulfilling the International Classification of Diseases(ICD-10)diagnostic criteria for schizophrenia were enrolled,and assigned into study group(n=30)and control group(n=30)using random number table methods.All patients were treated with olanzapine,and study group was given Zengye Chengqi decoction on this basis.Treatment for both groups lasted for 4 weeks.All participants were assessed using Positive and Negative Syndrome Scale(PANSS),Montreal Cognitive Assessment(MoCA)and Event-Related Potential P300 at baseline and end of treatment.The occurrence of adverse reactions was recorded at the end of treatment.Results Study group reported a higher treatment effective rate compared with control group(χ2=9.320,P=0.002).After treatment,study group detected a significant reduction in PANSS subscales and total scores(F=10.287,8.258,8.844,20.079,P<0.01),and a notable increase in scores of delayed recall and orientation domains from MoCA(F=4.463,22.255,P<0.05 or 0.01)when compared with control group,with statistical difference.For the P3 component of event-related potential,study group produced significantly larger amplitudes than control group(F=4.247,P<0.05).The incidence rate of abnormal liver function,constipation and increased body mass index(BMI)in study group was lower than those in control group(χ2=4.320,4.463,7.200,P<0.05 or 0.01).Conclusion Zengye Chengqi decoction combined with olanzapine are found to be effective in improving the psychotic symptoms and cognitive function and alleviating the adverse reactions of patients with schizophrenia of Yangming Fushi syndrome.
Author 杨世昌
王虹郁
邓丽
王维丽
崔桂梅
AuthorAffiliation 新乡医学院第二附属医院,河南 新乡 453002%新乡医学院第二附属医院,河南 新乡 453002;新乡市精神神经疾病中西医诊疗重点实验室,河南 新乡 453002
AuthorAffiliation_xml – name: 新乡医学院第二附属医院,河南 新乡 453002%新乡医学院第二附属医院,河南 新乡 453002;新乡市精神神经疾病中西医诊疗重点实验室,河南 新乡 453002
Author_FL Wang Weili
Wang Hongyu
Cui Guimei
Deng Li
Yang Shichang
Author_FL_xml – sequence: 1
  fullname: Wang Weili
– sequence: 2
  fullname: Deng Li
– sequence: 3
  fullname: Wang Hongyu
– sequence: 4
  fullname: Yang Shichang
– sequence: 5
  fullname: Cui Guimei
Author_xml – sequence: 1
  fullname: 王维丽
– sequence: 2
  fullname: 邓丽
– sequence: 3
  fullname: 王虹郁
– sequence: 4
  fullname: 杨世昌
– sequence: 5
  fullname: 崔桂梅
BookMark eNpNkM1Kw0AYAPdQwVr7Ar6Ap-i3u_nZHKX4BwUR9Fx2m6xYJAUX6VlRGxWqQrVFJIiaa6kpCCLo0-wmvoWCHjzNbQZmBpWidhQiNIdhAWPG3EXVbKmOIkBsIAQASAmVMYBnUeK406iq1K4AwBio70MZberHxLxm5uzTjPvm5VmfP-juZXHY11exTlMzHum3icne89vB13Bihr3i5FqPEp1c5NlHniY6Pi2ejvJBN787NjexSe5n0ZTkeyqs_rGCtleWt2prVn1jdb22VLcUBkItRnAghLCp7waM-lwQlwnhSAg4p9KnHsOYYNd2AEsvCJmkjk9kyAKberbdZLSC5n-9HR5JHu00Wu2D_ein2Pi3wAGg9BuGTG_-
ClassificationCodes R749.3
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.11886/scjsws20240220002
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Efficacy of Zengye Chengqi decoction combined with olanzapine in the treatment of schizophrenia of Yangming Fushi syndrome
EndPage 408
ExternalDocumentID scjsws202405003
GroupedDBID -05
2B.
4A8
92F
92I
93N
ABDBF
ABJNI
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
CCEZO
CCPQU
CIEJG
CW9
GROUPED_DOAJ
PHGZM
PHGZT
PIMPY
PMFND
PSX
PSYQQ
TCJ
TGQ
U1G
U5O
ID FETCH-LOGICAL-s1023-821dbbb4396d839ab268bb5f0daa3f9378112164501f7de8f3592fe8d43744c83
ISSN 1007-3256
IngestDate Thu May 29 03:55:14 EDT 2025
IsPeerReviewed false
IsScholarly false
Issue 5
Keywords 精神分裂症
Olanzapine
奥氮平
Schizophrenia
增液承气汤加减
阳明腑实型
Zengye Chengqi decoction
Yangming Fushi syndrome
Event-related potential P300
事件相关电位P300
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1023-821dbbb4396d839ab268bb5f0daa3f9378112164501f7de8f3592fe8d43744c83
PageCount 6
ParticipantIDs wanfang_journals_scjsws202405003
PublicationCentury 2000
PublicationDate 2024
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024
PublicationDecade 2020
PublicationTitle 四川精神卫生
PublicationTitle_FL Sichuan Mental Health
PublicationYear 2024
Publisher 新乡市精神神经疾病中西医诊疗重点实验室,河南 新乡 453002
新乡医学院第二附属医院,河南 新乡 453002%新乡医学院第二附属医院,河南 新乡 453002
Publisher_xml – name: 新乡医学院第二附属医院,河南 新乡 453002%新乡医学院第二附属医院,河南 新乡 453002
– name: 新乡市精神神经疾病中西医诊疗重点实验室,河南 新乡 453002
SSID ssib001103990
ssib051370907
ssib036439828
ssj0002912255
Score 1.9383591
Snippet R749.3; 背景 阳明腑实型精神分裂症患者症状较重,抗精神病药物的治疗效果有限且副反应较大.目前,缺乏增液承气汤治疗阳明腑实型精神分裂症的临床研究.目的 探讨增液承气汤加减联合奥氮平治疗阳明腑实型精神分裂症的效果,以期为精神分裂症的中西医结合治疗提供参考.方法...
SourceID wanfang
SourceType Aggregation Database
StartPage 403
Title 增液承气汤加减联合奥氮平治疗阳明腑实型精神分裂症的效果
URI https://d.wanfangdata.com.cn/periodical/scjsws202405003
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANJTtxYsfqPhZenBOZTWZj8zMMdlNKYJFpYXeSrJJFA8ruC1Cb4raquAHVFtEFlF7LbUFQQT9NcnWf-F7k-xubCt-QAiPN--9eR-TzJvJzMSyLrTsJI5wcWvLFnadi6hVD1MZ1mM3jSVTSZhI3O98ZdqdmuWX58TcSO1IZdXS4kJ0sbV04L6S_4kq4CCuuEv2HyI7EAoIgCG-cIcIw_2vYkwCQTxKdEACl_hwUQSUJv6kwdhEcwM4xONIrDzi2QaQRAGNgkTS0AiibaKUEWiugt0LEOODQGYwlPg-CSTRLtGSBJpoVRYBoAIjEEQ5Rk5gFBN4V4YL2QMEPFEWQY3KRS6PEUWNZIm6IeARZZTXhgwBENioJtNGuI8XKgkszd_U0iReoTYnerCSGRFqoJpPfKiNEx8Mag5JNKql2QElA2ZFtEYXIS1Y4QxJXNTIUyUz-Kz0U6M61UKHk6ym3PgdOTTxjB-BtXDNXsMqAKiP4TSBKWjQj6Ks2WsaFwvTLMAdDRNFwExig6iGE5uFcSLUiCYNogjKeMhYYKAx0Ua_QbDSxVpO7Ddgggtm25WpZVwuU2e0OOa93zcWB_KU7wBR6ei4zSo5EzdncxzQHStV_EH0VuduBz2K-7r7tf56zHmFRpjje0eplI6oWaN-MH31-jDFx7ULwy-7DDPqypdf4TBp63JKA7Mxqh3osoRZ9FAa2N87B8pd2qea2bzXTsP2jUqeOXPUOlwOEMe94mk_Zo0s3TxuXcved_PP2_nj7_nWav7pY_bkXbb8fPfeavZiJdvYyLc2sy87-fbX3uu1H-s7-fqz3Ycvs81u1n3a2_7W2-hmK492P9zvrS333jzIX63k3bcnrNnJYKYxVS9_hlLv4OkqdUWdOIoisNaNYVATRtRVUSRSOw5DlsIgQ8HIyXG5sJ1UxolKmdA0TVTMmeS8pdhJq9a-3U5OWeOxw3XMaKSobPFI8hBAoKMs4Y6GV_dpa7x0wXz5suvM7wnPmT-TnLUOIVxMV56zagt3FpPzkMAvRGNlTMfMBNhPw4e43g
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%A2%9E%E6%B6%B2%E6%89%BF%E6%B0%94%E6%B1%A4%E5%8A%A0%E5%87%8F%E8%81%94%E5%90%88%E5%A5%A5%E6%B0%AE%E5%B9%B3%E6%B2%BB%E7%96%97%E9%98%B3%E6%98%8E%E8%85%91%E5%AE%9E%E5%9E%8B%E7%B2%BE%E7%A5%9E%E5%88%86%E8%A3%82%E7%97%87%E7%9A%84%E6%95%88%E6%9E%9C&rft.jtitle=%E5%9B%9B%E5%B7%9D%E7%B2%BE%E7%A5%9E%E5%8D%AB%E7%94%9F&rft.au=%E7%8E%8B%E7%BB%B4%E4%B8%BD&rft.au=%E9%82%93%E4%B8%BD&rft.au=%E7%8E%8B%E8%99%B9%E9%83%81&rft.au=%E6%9D%A8%E4%B8%96%E6%98%8C&rft.date=2024&rft.pub=%E6%96%B0%E4%B9%A1%E5%B8%82%E7%B2%BE%E7%A5%9E%E7%A5%9E%E7%BB%8F%E7%96%BE%E7%97%85%E4%B8%AD%E8%A5%BF%E5%8C%BB%E8%AF%8A%E7%96%97%E9%87%8D%E7%82%B9%E5%AE%9E%E9%AA%8C%E5%AE%A4%2C%E6%B2%B3%E5%8D%97+%E6%96%B0%E4%B9%A1+453002&rft.issn=1007-3256&rft.volume=37&rft.issue=5&rft.spage=403&rft.epage=408&rft_id=info:doi/10.11886%2Fscjsws20240220002&rft.externalDocID=scjsws202405003
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fscjsws%2Fscjsws.jpg